Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.

Area of Science:

• Endocrinology
• Molecular Biology
• Pharmacology

Background:

• Selective estrogen receptor down-regulators (SERDs) are a class of antiestrogens that inhibit estrogen binding and promote receptor degradation.
• Approved SERDs like ICI 182,780 and investigational drugs like GW5638 are used in cancer treatment.
• Understanding mechanistic differences among SERDs is crucial for optimizing therapeutic strategies.

Purpose of the Study:

• To investigate potential functional and mechanistic distinctions between steroidal and nonsteroidal SERDs.
• To identify specific molecular interactions involved in SERD-mediated estrogen receptor alpha (ERalpha) degradation.
• To inform the development of new SERDs with improved pharmaceutical properties.

Main Methods:

• Comparative analysis of steroidal (ICI 182,780, RU58,668) and nonsteroidal (GW5638) SERDs.
• Investigation of ERalpha degradation pathways.
• Identification of protein-protein interaction surfaces on ERalpha.
• Development and validation of a high-throughput screen for novel SERDs.

Main Results:

• Both steroidal and nonsteroidal SERDs degrade ERalpha, but through different mechanisms.
• A specific protein-protein interaction surface on ERalpha is essential for ICI 182,780-induced degradation.
• This surface is also involved in degradation by RU58,668 but not by GW5638.
• GW5638 appears to down-regulate ERalpha via an alternative mechanism.

Conclusions:

• Mechanistic differences exist between steroidal and nonsteroidal SERDs, suggesting potential for sequential therapy.
• Insights into ICI 182,780's mechanism facilitated the development of a screen for improved orally active SERDs.
• Further research into SERD mechanisms can guide the development of more effective antiestrogen therapies.